Serena Mandla

Company: Noa Therapeutics

Job title: CSO and Co-Founder

Seminars:

Panel Discussion: Can Topical and Systemic Therapies Each Find Their Place in the Future of Dermatology Drug Development? 3:30 pm

How should we balance the clinical and commercial drivers behind topical and systemic innovation, especially as realworld prescribing habits continue to favor topicals? How are these approaches viewed from the patient, regulator and investor perspective? Which factors, including disease severity, body surface area, and treatment setting, best guide whether a topical, systemic, or combination approach…Read more

day: Day One PM